Service & Software
Global Gene Knockdown Market Research Report 2024
- Jan 20, 24
- ID: 11249
- Pages: 97
- Figures: 186
- Views: 16
The Gene Knockdown market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Knockdown market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Knockdown companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)
Segment by Type
siRNA
shRNA
Other
Segment by Application
Medical
Bioengineering
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Knockdown companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Knockdown companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Santa Cruz Biotechnology (US)
OriGene (US)
Sigma-Aldrich (US)
Abnova (Taiwan)
Agilent Technologies (US)
Bio-Rad (US)
Cell Signaling Technology (US)
GeneCopoeia (US)
siTOOLs Biotech (Germany)
Novus Biologicals (US)
EMD Millipore (US)
BioVision (US)
Creative Biomart (US)
Selleck Chemicals (US)
MyBioSource (US)
Invitrogen (US)
Qiagen (Germany)
Segment by Type
siRNA
shRNA
Other
Segment by Application
Medical
Bioengineering
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Knockdown companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Knockdown Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 siRNA
1.2.3 shRNA
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Knockdown Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Bioengineering
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Knockdown Market Perspective (2019-2030)
2.2 Gene Knockdown Growth Trends by Region
2.2.1 Global Gene Knockdown Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Knockdown Historic Market Size by Region (2019-2024)
2.2.3 Gene Knockdown Forecasted Market Size by Region (2025-2030)
2.3 Gene Knockdown Market Dynamics
2.3.1 Gene Knockdown Industry Trends
2.3.2 Gene Knockdown Market Drivers
2.3.3 Gene Knockdown Market Challenges
2.3.4 Gene Knockdown Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Knockdown Players by Revenue
3.1.1 Global Top Gene Knockdown Players by Revenue (2019-2024)
3.1.2 Global Gene Knockdown Revenue Market Share by Players (2019-2024)
3.2 Global Gene Knockdown Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Knockdown Revenue
3.4 Global Gene Knockdown Market Concentration Ratio
3.4.1 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Knockdown Revenue in 2023
3.5 Gene Knockdown Key Players Head office and Area Served
3.6 Key Players Gene Knockdown Product Solution and Service
3.7 Date of Enter into Gene Knockdown Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Knockdown Breakdown Data by Type
4.1 Global Gene Knockdown Historic Market Size by Type (2019-2024)
4.2 Global Gene Knockdown Forecasted Market Size by Type (2025-2030)
5 Gene Knockdown Breakdown Data by Application
5.1 Global Gene Knockdown Historic Market Size by Application (2019-2024)
5.2 Global Gene Knockdown Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Knockdown Market Size (2019-2030)
6.2 North America Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Knockdown Market Size by Country (2019-2024)
6.4 North America Gene Knockdown Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Knockdown Market Size (2019-2030)
7.2 Europe Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Knockdown Market Size by Country (2019-2024)
7.4 Europe Gene Knockdown Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Knockdown Market Size (2019-2030)
8.2 Asia-Pacific Gene Knockdown Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Knockdown Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Knockdown Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Knockdown Market Size (2019-2030)
9.2 Latin America Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Knockdown Market Size by Country (2019-2024)
9.4 Latin America Gene Knockdown Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Knockdown Market Size (2019-2030)
10.2 Middle East & Africa Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Knockdown Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Knockdown Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Santa Cruz Biotechnology (US)
11.1.1 Santa Cruz Biotechnology (US) Company Detail
11.1.2 Santa Cruz Biotechnology (US) Business Overview
11.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Introduction
11.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2019-2024)
11.1.5 Santa Cruz Biotechnology (US) Recent Development
11.2 OriGene (US)
11.2.1 OriGene (US) Company Detail
11.2.2 OriGene (US) Business Overview
11.2.3 OriGene (US) Gene Knockdown Introduction
11.2.4 OriGene (US) Revenue in Gene Knockdown Business (2019-2024)
11.2.5 OriGene (US) Recent Development
11.3 Sigma-Aldrich (US)
11.3.1 Sigma-Aldrich (US) Company Detail
11.3.2 Sigma-Aldrich (US) Business Overview
11.3.3 Sigma-Aldrich (US) Gene Knockdown Introduction
11.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2019-2024)
11.3.5 Sigma-Aldrich (US) Recent Development
11.4 Abnova (Taiwan)
11.4.1 Abnova (Taiwan) Company Detail
11.4.2 Abnova (Taiwan) Business Overview
11.4.3 Abnova (Taiwan) Gene Knockdown Introduction
11.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2019-2024)
11.4.5 Abnova (Taiwan) Recent Development
11.5 Agilent Technologies (US)
11.5.1 Agilent Technologies (US) Company Detail
11.5.2 Agilent Technologies (US) Business Overview
11.5.3 Agilent Technologies (US) Gene Knockdown Introduction
11.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2019-2024)
11.5.5 Agilent Technologies (US) Recent Development
11.6 Bio-Rad (US)
11.6.1 Bio-Rad (US) Company Detail
11.6.2 Bio-Rad (US) Business Overview
11.6.3 Bio-Rad (US) Gene Knockdown Introduction
11.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2019-2024)
11.6.5 Bio-Rad (US) Recent Development
11.7 Cell Signaling Technology (US)
11.7.1 Cell Signaling Technology (US) Company Detail
11.7.2 Cell Signaling Technology (US) Business Overview
11.7.3 Cell Signaling Technology (US) Gene Knockdown Introduction
11.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2019-2024)
11.7.5 Cell Signaling Technology (US) Recent Development
11.8 GeneCopoeia (US)
11.8.1 GeneCopoeia (US) Company Detail
11.8.2 GeneCopoeia (US) Business Overview
11.8.3 GeneCopoeia (US) Gene Knockdown Introduction
11.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2019-2024)
11.8.5 GeneCopoeia (US) Recent Development
11.9 siTOOLs Biotech (Germany)
11.9.1 siTOOLs Biotech (Germany) Company Detail
11.9.2 siTOOLs Biotech (Germany) Business Overview
11.9.3 siTOOLs Biotech (Germany) Gene Knockdown Introduction
11.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2019-2024)
11.9.5 siTOOLs Biotech (Germany) Recent Development
11.10 Novus Biologicals (US)
11.10.1 Novus Biologicals (US) Company Detail
11.10.2 Novus Biologicals (US) Business Overview
11.10.3 Novus Biologicals (US) Gene Knockdown Introduction
11.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2019-2024)
11.10.5 Novus Biologicals (US) Recent Development
11.11 EMD Millipore (US)
11.11.1 EMD Millipore (US) Company Detail
11.11.2 EMD Millipore (US) Business Overview
11.11.3 EMD Millipore (US) Gene Knockdown Introduction
11.11.4 EMD Millipore (US) Revenue in Gene Knockdown Business (2019-2024)
11.11.5 EMD Millipore (US) Recent Development
11.12 BioVision (US)
11.12.1 BioVision (US) Company Detail
11.12.2 BioVision (US) Business Overview
11.12.3 BioVision (US) Gene Knockdown Introduction
11.12.4 BioVision (US) Revenue in Gene Knockdown Business (2019-2024)
11.12.5 BioVision (US) Recent Development
11.13 Creative Biomart (US)
11.13.1 Creative Biomart (US) Company Detail
11.13.2 Creative Biomart (US) Business Overview
11.13.3 Creative Biomart (US) Gene Knockdown Introduction
11.13.4 Creative Biomart (US) Revenue in Gene Knockdown Business (2019-2024)
11.13.5 Creative Biomart (US) Recent Development
11.14 Selleck Chemicals (US)
11.14.1 Selleck Chemicals (US) Company Detail
11.14.2 Selleck Chemicals (US) Business Overview
11.14.3 Selleck Chemicals (US) Gene Knockdown Introduction
11.14.4 Selleck Chemicals (US) Revenue in Gene Knockdown Business (2019-2024)
11.14.5 Selleck Chemicals (US) Recent Development
11.15 MyBioSource (US)
11.15.1 MyBioSource (US) Company Detail
11.15.2 MyBioSource (US) Business Overview
11.15.3 MyBioSource (US) Gene Knockdown Introduction
11.15.4 MyBioSource (US) Revenue in Gene Knockdown Business (2019-2024)
11.15.5 MyBioSource (US) Recent Development
11.16 Invitrogen (US)
11.16.1 Invitrogen (US) Company Detail
11.16.2 Invitrogen (US) Business Overview
11.16.3 Invitrogen (US) Gene Knockdown Introduction
11.16.4 Invitrogen (US) Revenue in Gene Knockdown Business (2019-2024)
11.16.5 Invitrogen (US) Recent Development
11.17 Qiagen (Germany)
11.17.1 Qiagen (Germany) Company Detail
11.17.2 Qiagen (Germany) Business Overview
11.17.3 Qiagen (Germany) Gene Knockdown Introduction
11.17.4 Qiagen (Germany) Revenue in Gene Knockdown Business (2019-2024)
11.17.5 Qiagen (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Knockdown Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 siRNA
1.2.3 shRNA
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Knockdown Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Bioengineering
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Knockdown Market Perspective (2019-2030)
2.2 Gene Knockdown Growth Trends by Region
2.2.1 Global Gene Knockdown Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Knockdown Historic Market Size by Region (2019-2024)
2.2.3 Gene Knockdown Forecasted Market Size by Region (2025-2030)
2.3 Gene Knockdown Market Dynamics
2.3.1 Gene Knockdown Industry Trends
2.3.2 Gene Knockdown Market Drivers
2.3.3 Gene Knockdown Market Challenges
2.3.4 Gene Knockdown Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Knockdown Players by Revenue
3.1.1 Global Top Gene Knockdown Players by Revenue (2019-2024)
3.1.2 Global Gene Knockdown Revenue Market Share by Players (2019-2024)
3.2 Global Gene Knockdown Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Knockdown Revenue
3.4 Global Gene Knockdown Market Concentration Ratio
3.4.1 Global Gene Knockdown Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Knockdown Revenue in 2023
3.5 Gene Knockdown Key Players Head office and Area Served
3.6 Key Players Gene Knockdown Product Solution and Service
3.7 Date of Enter into Gene Knockdown Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Knockdown Breakdown Data by Type
4.1 Global Gene Knockdown Historic Market Size by Type (2019-2024)
4.2 Global Gene Knockdown Forecasted Market Size by Type (2025-2030)
5 Gene Knockdown Breakdown Data by Application
5.1 Global Gene Knockdown Historic Market Size by Application (2019-2024)
5.2 Global Gene Knockdown Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Knockdown Market Size (2019-2030)
6.2 North America Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Knockdown Market Size by Country (2019-2024)
6.4 North America Gene Knockdown Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Knockdown Market Size (2019-2030)
7.2 Europe Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Knockdown Market Size by Country (2019-2024)
7.4 Europe Gene Knockdown Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Knockdown Market Size (2019-2030)
8.2 Asia-Pacific Gene Knockdown Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Knockdown Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Knockdown Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Knockdown Market Size (2019-2030)
9.2 Latin America Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Knockdown Market Size by Country (2019-2024)
9.4 Latin America Gene Knockdown Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Knockdown Market Size (2019-2030)
10.2 Middle East & Africa Gene Knockdown Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Knockdown Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Knockdown Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Santa Cruz Biotechnology (US)
11.1.1 Santa Cruz Biotechnology (US) Company Detail
11.1.2 Santa Cruz Biotechnology (US) Business Overview
11.1.3 Santa Cruz Biotechnology (US) Gene Knockdown Introduction
11.1.4 Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2019-2024)
11.1.5 Santa Cruz Biotechnology (US) Recent Development
11.2 OriGene (US)
11.2.1 OriGene (US) Company Detail
11.2.2 OriGene (US) Business Overview
11.2.3 OriGene (US) Gene Knockdown Introduction
11.2.4 OriGene (US) Revenue in Gene Knockdown Business (2019-2024)
11.2.5 OriGene (US) Recent Development
11.3 Sigma-Aldrich (US)
11.3.1 Sigma-Aldrich (US) Company Detail
11.3.2 Sigma-Aldrich (US) Business Overview
11.3.3 Sigma-Aldrich (US) Gene Knockdown Introduction
11.3.4 Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2019-2024)
11.3.5 Sigma-Aldrich (US) Recent Development
11.4 Abnova (Taiwan)
11.4.1 Abnova (Taiwan) Company Detail
11.4.2 Abnova (Taiwan) Business Overview
11.4.3 Abnova (Taiwan) Gene Knockdown Introduction
11.4.4 Abnova (Taiwan) Revenue in Gene Knockdown Business (2019-2024)
11.4.5 Abnova (Taiwan) Recent Development
11.5 Agilent Technologies (US)
11.5.1 Agilent Technologies (US) Company Detail
11.5.2 Agilent Technologies (US) Business Overview
11.5.3 Agilent Technologies (US) Gene Knockdown Introduction
11.5.4 Agilent Technologies (US) Revenue in Gene Knockdown Business (2019-2024)
11.5.5 Agilent Technologies (US) Recent Development
11.6 Bio-Rad (US)
11.6.1 Bio-Rad (US) Company Detail
11.6.2 Bio-Rad (US) Business Overview
11.6.3 Bio-Rad (US) Gene Knockdown Introduction
11.6.4 Bio-Rad (US) Revenue in Gene Knockdown Business (2019-2024)
11.6.5 Bio-Rad (US) Recent Development
11.7 Cell Signaling Technology (US)
11.7.1 Cell Signaling Technology (US) Company Detail
11.7.2 Cell Signaling Technology (US) Business Overview
11.7.3 Cell Signaling Technology (US) Gene Knockdown Introduction
11.7.4 Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2019-2024)
11.7.5 Cell Signaling Technology (US) Recent Development
11.8 GeneCopoeia (US)
11.8.1 GeneCopoeia (US) Company Detail
11.8.2 GeneCopoeia (US) Business Overview
11.8.3 GeneCopoeia (US) Gene Knockdown Introduction
11.8.4 GeneCopoeia (US) Revenue in Gene Knockdown Business (2019-2024)
11.8.5 GeneCopoeia (US) Recent Development
11.9 siTOOLs Biotech (Germany)
11.9.1 siTOOLs Biotech (Germany) Company Detail
11.9.2 siTOOLs Biotech (Germany) Business Overview
11.9.3 siTOOLs Biotech (Germany) Gene Knockdown Introduction
11.9.4 siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2019-2024)
11.9.5 siTOOLs Biotech (Germany) Recent Development
11.10 Novus Biologicals (US)
11.10.1 Novus Biologicals (US) Company Detail
11.10.2 Novus Biologicals (US) Business Overview
11.10.3 Novus Biologicals (US) Gene Knockdown Introduction
11.10.4 Novus Biologicals (US) Revenue in Gene Knockdown Business (2019-2024)
11.10.5 Novus Biologicals (US) Recent Development
11.11 EMD Millipore (US)
11.11.1 EMD Millipore (US) Company Detail
11.11.2 EMD Millipore (US) Business Overview
11.11.3 EMD Millipore (US) Gene Knockdown Introduction
11.11.4 EMD Millipore (US) Revenue in Gene Knockdown Business (2019-2024)
11.11.5 EMD Millipore (US) Recent Development
11.12 BioVision (US)
11.12.1 BioVision (US) Company Detail
11.12.2 BioVision (US) Business Overview
11.12.3 BioVision (US) Gene Knockdown Introduction
11.12.4 BioVision (US) Revenue in Gene Knockdown Business (2019-2024)
11.12.5 BioVision (US) Recent Development
11.13 Creative Biomart (US)
11.13.1 Creative Biomart (US) Company Detail
11.13.2 Creative Biomart (US) Business Overview
11.13.3 Creative Biomart (US) Gene Knockdown Introduction
11.13.4 Creative Biomart (US) Revenue in Gene Knockdown Business (2019-2024)
11.13.5 Creative Biomart (US) Recent Development
11.14 Selleck Chemicals (US)
11.14.1 Selleck Chemicals (US) Company Detail
11.14.2 Selleck Chemicals (US) Business Overview
11.14.3 Selleck Chemicals (US) Gene Knockdown Introduction
11.14.4 Selleck Chemicals (US) Revenue in Gene Knockdown Business (2019-2024)
11.14.5 Selleck Chemicals (US) Recent Development
11.15 MyBioSource (US)
11.15.1 MyBioSource (US) Company Detail
11.15.2 MyBioSource (US) Business Overview
11.15.3 MyBioSource (US) Gene Knockdown Introduction
11.15.4 MyBioSource (US) Revenue in Gene Knockdown Business (2019-2024)
11.15.5 MyBioSource (US) Recent Development
11.16 Invitrogen (US)
11.16.1 Invitrogen (US) Company Detail
11.16.2 Invitrogen (US) Business Overview
11.16.3 Invitrogen (US) Gene Knockdown Introduction
11.16.4 Invitrogen (US) Revenue in Gene Knockdown Business (2019-2024)
11.16.5 Invitrogen (US) Recent Development
11.17 Qiagen (Germany)
11.17.1 Qiagen (Germany) Company Detail
11.17.2 Qiagen (Germany) Business Overview
11.17.3 Qiagen (Germany) Gene Knockdown Introduction
11.17.4 Qiagen (Germany) Revenue in Gene Knockdown Business (2019-2024)
11.17.5 Qiagen (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gene Knockdown Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of siRNA
Table 3. Key Players of shRNA
Table 4. Key Players of Other
Table 5. Global Gene Knockdown Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene Knockdown Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Gene Knockdown Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Gene Knockdown Market Share by Region (2019-2024)
Table 9. Global Gene Knockdown Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Gene Knockdown Market Share by Region (2025-2030)
Table 11. Gene Knockdown Market Trends
Table 12. Gene Knockdown Market Drivers
Table 13. Gene Knockdown Market Challenges
Table 14. Gene Knockdown Market Restraints
Table 15. Global Gene Knockdown Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Gene Knockdown Market Share by Players (2019-2024)
Table 17. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown as of 2023)
Table 18. Ranking of Global Top Gene Knockdown Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Gene Knockdown Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Knockdown Product Solution and Service
Table 22. Date of Enter into Gene Knockdown Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Knockdown Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Gene Knockdown Revenue Market Share by Type (2019-2024)
Table 26. Global Gene Knockdown Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Gene Knockdown Revenue Market Share by Type (2025-2030)
Table 28. Global Gene Knockdown Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Gene Knockdown Revenue Market Share by Application (2019-2024)
Table 30. Global Gene Knockdown Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Gene Knockdown Revenue Market Share by Application (2025-2030)
Table 32. North America Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Gene Knockdown Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Gene Knockdown Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Gene Knockdown Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 47. Santa Cruz Biotechnology (US) Company Detail
Table 48. Santa Cruz Biotechnology (US) Business Overview
Table 49. Santa Cruz Biotechnology (US) Gene Knockdown Product
Table 50. Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 51. Santa Cruz Biotechnology (US) Recent Development
Table 52. OriGene (US) Company Detail
Table 53. OriGene (US) Business Overview
Table 54. OriGene (US) Gene Knockdown Product
Table 55. OriGene (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 56. OriGene (US) Recent Development
Table 57. Sigma-Aldrich (US) Company Detail
Table 58. Sigma-Aldrich (US) Business Overview
Table 59. Sigma-Aldrich (US) Gene Knockdown Product
Table 60. Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 61. Sigma-Aldrich (US) Recent Development
Table 62. Abnova (Taiwan) Company Detail
Table 63. Abnova (Taiwan) Business Overview
Table 64. Abnova (Taiwan) Gene Knockdown Product
Table 65. Abnova (Taiwan) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 66. Abnova (Taiwan) Recent Development
Table 67. Agilent Technologies (US) Company Detail
Table 68. Agilent Technologies (US) Business Overview
Table 69. Agilent Technologies (US) Gene Knockdown Product
Table 70. Agilent Technologies (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 71. Agilent Technologies (US) Recent Development
Table 72. Bio-Rad (US) Company Detail
Table 73. Bio-Rad (US) Business Overview
Table 74. Bio-Rad (US) Gene Knockdown Product
Table 75. Bio-Rad (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 76. Bio-Rad (US) Recent Development
Table 77. Cell Signaling Technology (US) Company Detail
Table 78. Cell Signaling Technology (US) Business Overview
Table 79. Cell Signaling Technology (US) Gene Knockdown Product
Table 80. Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 81. Cell Signaling Technology (US) Recent Development
Table 82. GeneCopoeia (US) Company Detail
Table 83. GeneCopoeia (US) Business Overview
Table 84. GeneCopoeia (US) Gene Knockdown Product
Table 85. GeneCopoeia (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 86. GeneCopoeia (US) Recent Development
Table 87. siTOOLs Biotech (Germany) Company Detail
Table 88. siTOOLs Biotech (Germany) Business Overview
Table 89. siTOOLs Biotech (Germany) Gene Knockdown Product
Table 90. siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 91. siTOOLs Biotech (Germany) Recent Development
Table 92. Novus Biologicals (US) Company Detail
Table 93. Novus Biologicals (US) Business Overview
Table 94. Novus Biologicals (US) Gene Knockdown Product
Table 95. Novus Biologicals (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 96. Novus Biologicals (US) Recent Development
Table 97. EMD Millipore (US) Company Detail
Table 98. EMD Millipore (US) Business Overview
Table 99. EMD Millipore (US) Gene Knockdown Product
Table 100. EMD Millipore (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 101. EMD Millipore (US) Recent Development
Table 102. BioVision (US) Company Detail
Table 103. BioVision (US) Business Overview
Table 104. BioVision (US) Gene Knockdown Product
Table 105. BioVision (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 106. BioVision (US) Recent Development
Table 107. Creative Biomart (US) Company Detail
Table 108. Creative Biomart (US) Business Overview
Table 109. Creative Biomart (US) Gene Knockdown Product
Table 110. Creative Biomart (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 111. Creative Biomart (US) Recent Development
Table 112. Selleck Chemicals (US) Company Detail
Table 113. Selleck Chemicals (US) Business Overview
Table 114. Selleck Chemicals (US) Gene Knockdown Product
Table 115. Selleck Chemicals (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 116. Selleck Chemicals (US) Recent Development
Table 117. MyBioSource (US) Company Detail
Table 118. MyBioSource (US) Business Overview
Table 119. MyBioSource (US) Gene Knockdown Product
Table 120. MyBioSource (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 121. MyBioSource (US) Recent Development
Table 122. Invitrogen (US) Company Detail
Table 123. Invitrogen (US) Business Overview
Table 124. Invitrogen (US) Gene Knockdown Product
Table 125. Invitrogen (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 126. Invitrogen (US) Recent Development
Table 127. Qiagen (Germany) Company Detail
Table 128. Qiagen (Germany) Business Overview
Table 129. Qiagen (Germany) Gene Knockdown Product
Table 130. Qiagen (Germany) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 131. Qiagen (Germany) Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Knockdown Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Knockdown Market Share by Type: 2023 VS 2030
Figure 3. siRNA Features
Figure 4. shRNA Features
Figure 5. Other Features
Figure 6. Global Gene Knockdown Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gene Knockdown Market Share by Application: 2023 VS 2030
Figure 8. Medical Case Studies
Figure 9. Bioengineering Case Studies
Figure 10. Other Case Studies
Figure 11. Gene Knockdown Report Years Considered
Figure 12. Global Gene Knockdown Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Gene Knockdown Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Gene Knockdown Market Share by Region: 2023 VS 2030
Figure 15. Global Gene Knockdown Market Share by Players in 2023
Figure 16. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Gene Knockdown Revenue in 2023
Figure 18. North America Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Gene Knockdown Market Share by Country (2019-2030)
Figure 20. United States Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Gene Knockdown Market Share by Country (2019-2030)
Figure 24. Germany Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Gene Knockdown Market Share by Region (2019-2030)
Figure 32. China Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Gene Knockdown Market Share by Country (2019-2030)
Figure 40. Mexico Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Gene Knockdown Market Share by Country (2019-2030)
Figure 44. Turkey Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Santa Cruz Biotechnology (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 47. OriGene (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 48. Sigma-Aldrich (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 49. Abnova (Taiwan) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 50. Agilent Technologies (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 51. Bio-Rad (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 52. Cell Signaling Technology (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 53. GeneCopoeia (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 54. siTOOLs Biotech (Germany) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 55. Novus Biologicals (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 56. EMD Millipore (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 57. BioVision (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 58. Creative Biomart (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 59. Selleck Chemicals (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 60. MyBioSource (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 61. Invitrogen (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 62. Qiagen (Germany) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Gene Knockdown Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of siRNA
Table 3. Key Players of shRNA
Table 4. Key Players of Other
Table 5. Global Gene Knockdown Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene Knockdown Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Gene Knockdown Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Gene Knockdown Market Share by Region (2019-2024)
Table 9. Global Gene Knockdown Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Gene Knockdown Market Share by Region (2025-2030)
Table 11. Gene Knockdown Market Trends
Table 12. Gene Knockdown Market Drivers
Table 13. Gene Knockdown Market Challenges
Table 14. Gene Knockdown Market Restraints
Table 15. Global Gene Knockdown Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Gene Knockdown Market Share by Players (2019-2024)
Table 17. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown as of 2023)
Table 18. Ranking of Global Top Gene Knockdown Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Gene Knockdown Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Knockdown Product Solution and Service
Table 22. Date of Enter into Gene Knockdown Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Knockdown Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Gene Knockdown Revenue Market Share by Type (2019-2024)
Table 26. Global Gene Knockdown Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Gene Knockdown Revenue Market Share by Type (2025-2030)
Table 28. Global Gene Knockdown Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Gene Knockdown Revenue Market Share by Application (2019-2024)
Table 30. Global Gene Knockdown Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Gene Knockdown Revenue Market Share by Application (2025-2030)
Table 32. North America Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Gene Knockdown Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Gene Knockdown Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Gene Knockdown Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Gene Knockdown Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Gene Knockdown Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Gene Knockdown Market Size by Country (2025-2030) & (US$ Million)
Table 47. Santa Cruz Biotechnology (US) Company Detail
Table 48. Santa Cruz Biotechnology (US) Business Overview
Table 49. Santa Cruz Biotechnology (US) Gene Knockdown Product
Table 50. Santa Cruz Biotechnology (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 51. Santa Cruz Biotechnology (US) Recent Development
Table 52. OriGene (US) Company Detail
Table 53. OriGene (US) Business Overview
Table 54. OriGene (US) Gene Knockdown Product
Table 55. OriGene (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 56. OriGene (US) Recent Development
Table 57. Sigma-Aldrich (US) Company Detail
Table 58. Sigma-Aldrich (US) Business Overview
Table 59. Sigma-Aldrich (US) Gene Knockdown Product
Table 60. Sigma-Aldrich (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 61. Sigma-Aldrich (US) Recent Development
Table 62. Abnova (Taiwan) Company Detail
Table 63. Abnova (Taiwan) Business Overview
Table 64. Abnova (Taiwan) Gene Knockdown Product
Table 65. Abnova (Taiwan) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 66. Abnova (Taiwan) Recent Development
Table 67. Agilent Technologies (US) Company Detail
Table 68. Agilent Technologies (US) Business Overview
Table 69. Agilent Technologies (US) Gene Knockdown Product
Table 70. Agilent Technologies (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 71. Agilent Technologies (US) Recent Development
Table 72. Bio-Rad (US) Company Detail
Table 73. Bio-Rad (US) Business Overview
Table 74. Bio-Rad (US) Gene Knockdown Product
Table 75. Bio-Rad (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 76. Bio-Rad (US) Recent Development
Table 77. Cell Signaling Technology (US) Company Detail
Table 78. Cell Signaling Technology (US) Business Overview
Table 79. Cell Signaling Technology (US) Gene Knockdown Product
Table 80. Cell Signaling Technology (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 81. Cell Signaling Technology (US) Recent Development
Table 82. GeneCopoeia (US) Company Detail
Table 83. GeneCopoeia (US) Business Overview
Table 84. GeneCopoeia (US) Gene Knockdown Product
Table 85. GeneCopoeia (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 86. GeneCopoeia (US) Recent Development
Table 87. siTOOLs Biotech (Germany) Company Detail
Table 88. siTOOLs Biotech (Germany) Business Overview
Table 89. siTOOLs Biotech (Germany) Gene Knockdown Product
Table 90. siTOOLs Biotech (Germany) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 91. siTOOLs Biotech (Germany) Recent Development
Table 92. Novus Biologicals (US) Company Detail
Table 93. Novus Biologicals (US) Business Overview
Table 94. Novus Biologicals (US) Gene Knockdown Product
Table 95. Novus Biologicals (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 96. Novus Biologicals (US) Recent Development
Table 97. EMD Millipore (US) Company Detail
Table 98. EMD Millipore (US) Business Overview
Table 99. EMD Millipore (US) Gene Knockdown Product
Table 100. EMD Millipore (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 101. EMD Millipore (US) Recent Development
Table 102. BioVision (US) Company Detail
Table 103. BioVision (US) Business Overview
Table 104. BioVision (US) Gene Knockdown Product
Table 105. BioVision (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 106. BioVision (US) Recent Development
Table 107. Creative Biomart (US) Company Detail
Table 108. Creative Biomart (US) Business Overview
Table 109. Creative Biomart (US) Gene Knockdown Product
Table 110. Creative Biomart (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 111. Creative Biomart (US) Recent Development
Table 112. Selleck Chemicals (US) Company Detail
Table 113. Selleck Chemicals (US) Business Overview
Table 114. Selleck Chemicals (US) Gene Knockdown Product
Table 115. Selleck Chemicals (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 116. Selleck Chemicals (US) Recent Development
Table 117. MyBioSource (US) Company Detail
Table 118. MyBioSource (US) Business Overview
Table 119. MyBioSource (US) Gene Knockdown Product
Table 120. MyBioSource (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 121. MyBioSource (US) Recent Development
Table 122. Invitrogen (US) Company Detail
Table 123. Invitrogen (US) Business Overview
Table 124. Invitrogen (US) Gene Knockdown Product
Table 125. Invitrogen (US) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 126. Invitrogen (US) Recent Development
Table 127. Qiagen (Germany) Company Detail
Table 128. Qiagen (Germany) Business Overview
Table 129. Qiagen (Germany) Gene Knockdown Product
Table 130. Qiagen (Germany) Revenue in Gene Knockdown Business (2019-2024) & (US$ Million)
Table 131. Qiagen (Germany) Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Knockdown Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Knockdown Market Share by Type: 2023 VS 2030
Figure 3. siRNA Features
Figure 4. shRNA Features
Figure 5. Other Features
Figure 6. Global Gene Knockdown Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gene Knockdown Market Share by Application: 2023 VS 2030
Figure 8. Medical Case Studies
Figure 9. Bioengineering Case Studies
Figure 10. Other Case Studies
Figure 11. Gene Knockdown Report Years Considered
Figure 12. Global Gene Knockdown Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Gene Knockdown Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Gene Knockdown Market Share by Region: 2023 VS 2030
Figure 15. Global Gene Knockdown Market Share by Players in 2023
Figure 16. Global Top Gene Knockdown Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockdown as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Gene Knockdown Revenue in 2023
Figure 18. North America Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Gene Knockdown Market Share by Country (2019-2030)
Figure 20. United States Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Gene Knockdown Market Share by Country (2019-2030)
Figure 24. Germany Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Gene Knockdown Market Share by Region (2019-2030)
Figure 32. China Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Gene Knockdown Market Share by Country (2019-2030)
Figure 40. Mexico Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Gene Knockdown Market Share by Country (2019-2030)
Figure 44. Turkey Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Gene Knockdown Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Santa Cruz Biotechnology (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 47. OriGene (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 48. Sigma-Aldrich (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 49. Abnova (Taiwan) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 50. Agilent Technologies (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 51. Bio-Rad (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 52. Cell Signaling Technology (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 53. GeneCopoeia (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 54. siTOOLs Biotech (Germany) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 55. Novus Biologicals (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 56. EMD Millipore (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 57. BioVision (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 58. Creative Biomart (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 59. Selleck Chemicals (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 60. MyBioSource (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 61. Invitrogen (US) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 62. Qiagen (Germany) Revenue Growth Rate in Gene Knockdown Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232